Eton Pharmaceuticals (ETON) Non-Current Assets (2017 - 2025)

Eton Pharmaceuticals (ETON) has 9 years of Non-Current Assets data on file, last reported at $31.5 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Assets fell 10.17% year-over-year to $31.5 million; the trailing twelve-month figure through Dec 2025 stood at $131.3 million (up 142.72% YoY), and the FY2025 full-year result was $31.5 million, down 10.17% from the prior year.
• Non-Current Assets slipped to $31.5 million in Q4 2025, from $32.5 million in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $35.1 million in Q4 2024 to a low of $743000.0 in Q3 2021.
• A 5-year average of $11.4 million and a median of $5.0 million in 2022 frame the typical range for Non-Current Assets.
• Across the five-year window, Non-Current Assets tumbled 53.85% in 2021 and jumped 616.22% in 2024, its largest moves.
• Tracing ETON's Non-Current Assets over 5 years: stood at $3.9 million in 2021, then soared by 30.17% to $5.0 million in 2022, then decreased by 2.49% to $4.9 million in 2023, then jumped by 616.22% to $35.1 million in 2024, then declined by 10.17% to $31.5 million in 2025.
• Business Quant data shows ETON's Non-Current Assets at $31.5 million in Q4 2025, $32.5 million in Q3 2025, and $33.2 million in Q2 2025.